Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalization

Sodium taurocholate cotransporting polypeptide (NTCP) is a host cell receptor required for hepatitis B virus (HBV) entry. However, the susceptibility of NTCP-expressing cells to HBV is diverse depending on the culture condition. Stimulation with epidermal growth factor (EGF) was found to potentiate...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 116; no. 17; pp. 8487 - 8492
Main Authors Iwamoto, Masashi, Saso, Wakana, Sugiyama, Ryuichi, Ishii, Koji, Ohki, Mio, Nagamori, Shushi, Suzuki, Ryosuke, Aizaki, Hideki, Ryo, Akihide, Yun, Ji-Hye, Park, Sam-Yong, Ohtani, Naoko, Muramatsu, Masamichi, Iwami, Shingo, Tanaka, Yasuhito, Sureau, Camille, Wakita, Takaji, Watashi, Koichi
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 23.04.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Sodium taurocholate cotransporting polypeptide (NTCP) is a host cell receptor required for hepatitis B virus (HBV) entry. However, the susceptibility of NTCP-expressing cells to HBV is diverse depending on the culture condition. Stimulation with epidermal growth factor (EGF) was found to potentiate cell susceptibility to HBV infection. Here, we show that EGF receptor (EGFR) plays a critical role in HBV virion internalization. In EGFR-knockdown cells, HBV or its preS1-specific fluorescence peptide attached to the cell surface, but its internalization was attenuated. PreS1 internalization and HBV infection could be rescued by complementation with functional EGFR. Interestingly, the HBV/preS1–NTCP complex at the cell surface was internalized concomitant with the endocytotic relocalization of EGFR. Molecular interaction between NTCP and EGFR was documented by immunoprecipitation assay. Upon dissociation from functional EGFR, NTCP no longer functioned to support viral infection, as demonstrated by either (i) the introduction of NTCP pointmutation that disrupted its interaction with EGFR, (ii) the detrimental effect of decoy peptide interrupting the NTCP–EGFR interaction, or (iii) the pharmacological inactivation of EGFR. Together, these data support the crucial role of EGFR in mediating HBV–NTCP internalization into susceptible cells. EGFR thus provides a yet unidentified missing link from the cell-surface HBV–NTCP attachment to the viral invasion beyond the host cell membrane
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMCID: PMC6486715
Edited by Francis V. Chisari, The Scripps Research Institute, La Jolla, CA, and approved March 12, 2019 (received for review June 27, 2018)
Author contributions: M.I. and K.W. designed research; M.I., W.S., R. Sugiyama, and K.W. performed research; M.O., A.R., J.-H.Y., S.-Y.P., C.S., and K.W. contributed new reagents/analytic tools; M.I., W.S., R. Sugiyama, K.I., S.N., R. Suzuki, H.A., N.O., M.M., S.I., Y.T., T.W., and K.W. analyzed data; and M.I. and K.W. wrote the paper.
ISSN:0027-8424
1091-6490
1091-6490
DOI:10.1073/pnas.1811064116